2026 Q1 -tulosraportti
98 päivää sitten
‧46 min
1,55 DKK/osake
Viimeisin osinko
0,00%Tuotto/v
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. | 7 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 5.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 1.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·7 t sittenAre you selling out before the earnings report or are you holding now that it's above and stays above 100 right now?
I wouldn't dare to sell into this financial report; last time I considered it a lot, as I had expected that one wouldn't see an impact from evolve 3 75 and 85 since they had only just come onto the market and only in one color variant. But I didn't do it, because one couldn't know if they would announce something that would move the shorters.
·1 päivä sittenIt will at some point be a fantastic day when all those who have shorted the stock get a beating - I look forward to this day.
·1 päivä sittenWow, what a nice cross😊Is there anything you want to elaborate on, and what are your thoughts? TA is not my strong suit, which setting did you use? That short goes down a bit, and the price slightly up, that's easy to ascertain.
·1 päivä sittenGN Store Nord: Demant's report makes me more positive before GN's Q2 📈 Demant's new Q2/H1 report I actually find very interesting for GN. Demant delivered 10 % organic growth in external Hearing Aids sales in Q2, while the global hearing aid market, according to Demant, only grew by about 3 % in volume. At the same time, Demant raised its full-year organic growth expectation from 3-6% to 6-7% and EBIT guidance from DKK 4.1-4.5 bn to DKK 4.4-4.8 bn. This tells me first and foremost that the hearing aid market looks healthier than feared, and that innovation and new premium products can continue to create significant market share gains. This becomes very interesting for GN, because GN Hearing already delivered 9% organic growth in Q1. My expectation before GN's next report is therefore that Hearing can again deliver a strong quarter. A level around 7-9 % organic growth in Q2 will, in my assessment, be realistic, but that is my own estimate AND not GN's guidance. It is also positive for the value of the agreed DKK 17 bn transaction with Amplifon. GN is selling Hearing at a time when the industry is showing growth, product innovation, and opportunities for market share gains. But the biggest wildcard for the GN share will be Enterprise. If GN can combine: - 7-9 % Hearing growth - stabilization in Enterprise after -5 % in Q1 - better Gaming growth - maintained guidance - Amplifon transaction still on track ...then I think we have a fundamentally much stronger setup than the share price around DKK 100 immediately signals. And then the short positioning comes on top. Short interest, according to the latest data we have seen, has fallen from about 11.43% to 9.67%. That is still very high, but the direction is interesting. I am not building the GN case on a short squeeze. It must be the report, improved operations, and the value realization from Hearing that drives the share. But if GN delivers, while short positions continue to fall, it can naturally amplify the share price reaction. Demant's report is not proof that GN will deliver a strong Q2. Demant itself is gaining market share, and that must be respected. But as an industry read-through, I clearly think yesterday's report is positive for GN. Now GN itself must deliver. If Enterprise starts to turn around simultaneously with continued strong Hearing, DKK 100 could, in my assessment, become a much more interesting level than the market currently suggests. 🚀 Good luck to all GN shareholders.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
98 päivää sitten
‧46 min
1,55 DKK/osake
Viimeisin osinko
0,00%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·7 t sittenAre you selling out before the earnings report or are you holding now that it's above and stays above 100 right now?I wouldn't dare to sell into this financial report; last time I considered it a lot, as I had expected that one wouldn't see an impact from evolve 3 75 and 85 since they had only just come onto the market and only in one color variant. But I didn't do it, because one couldn't know if they would announce something that would move the shorters.
- ·1 päivä sittenIt will at some point be a fantastic day when all those who have shorted the stock get a beating - I look forward to this day.
- ·1 päivä sittenWow, what a nice cross😊Is there anything you want to elaborate on, and what are your thoughts? TA is not my strong suit, which setting did you use? That short goes down a bit, and the price slightly up, that's easy to ascertain.
- ·1 päivä sittenGN Store Nord: Demant's report makes me more positive before GN's Q2 📈 Demant's new Q2/H1 report I actually find very interesting for GN. Demant delivered 10 % organic growth in external Hearing Aids sales in Q2, while the global hearing aid market, according to Demant, only grew by about 3 % in volume. At the same time, Demant raised its full-year organic growth expectation from 3-6% to 6-7% and EBIT guidance from DKK 4.1-4.5 bn to DKK 4.4-4.8 bn. This tells me first and foremost that the hearing aid market looks healthier than feared, and that innovation and new premium products can continue to create significant market share gains. This becomes very interesting for GN, because GN Hearing already delivered 9% organic growth in Q1. My expectation before GN's next report is therefore that Hearing can again deliver a strong quarter. A level around 7-9 % organic growth in Q2 will, in my assessment, be realistic, but that is my own estimate AND not GN's guidance. It is also positive for the value of the agreed DKK 17 bn transaction with Amplifon. GN is selling Hearing at a time when the industry is showing growth, product innovation, and opportunities for market share gains. But the biggest wildcard for the GN share will be Enterprise. If GN can combine: - 7-9 % Hearing growth - stabilization in Enterprise after -5 % in Q1 - better Gaming growth - maintained guidance - Amplifon transaction still on track ...then I think we have a fundamentally much stronger setup than the share price around DKK 100 immediately signals. And then the short positioning comes on top. Short interest, according to the latest data we have seen, has fallen from about 11.43% to 9.67%. That is still very high, but the direction is interesting. I am not building the GN case on a short squeeze. It must be the report, improved operations, and the value realization from Hearing that drives the share. But if GN delivers, while short positions continue to fall, it can naturally amplify the share price reaction. Demant's report is not proof that GN will deliver a strong Q2. Demant itself is gaining market share, and that must be respected. But as an industry read-through, I clearly think yesterday's report is positive for GN. Now GN itself must deliver. If Enterprise starts to turn around simultaneously with continued strong Hearing, DKK 100 could, in my assessment, become a much more interesting level than the market currently suggests. 🚀 Good luck to all GN shareholders.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. | 7 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 5.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 1.5.2025 |
2026 Q1 -tulosraportti
98 päivää sitten
‧46 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. | 7 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 5.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 1.5.2025 |
1,55 DKK/osake
Viimeisin osinko
0,00%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·7 t sittenAre you selling out before the earnings report or are you holding now that it's above and stays above 100 right now?I wouldn't dare to sell into this financial report; last time I considered it a lot, as I had expected that one wouldn't see an impact from evolve 3 75 and 85 since they had only just come onto the market and only in one color variant. But I didn't do it, because one couldn't know if they would announce something that would move the shorters.
- ·1 päivä sittenIt will at some point be a fantastic day when all those who have shorted the stock get a beating - I look forward to this day.
- ·1 päivä sittenWow, what a nice cross😊Is there anything you want to elaborate on, and what are your thoughts? TA is not my strong suit, which setting did you use? That short goes down a bit, and the price slightly up, that's easy to ascertain.
- ·1 päivä sittenGN Store Nord: Demant's report makes me more positive before GN's Q2 📈 Demant's new Q2/H1 report I actually find very interesting for GN. Demant delivered 10 % organic growth in external Hearing Aids sales in Q2, while the global hearing aid market, according to Demant, only grew by about 3 % in volume. At the same time, Demant raised its full-year organic growth expectation from 3-6% to 6-7% and EBIT guidance from DKK 4.1-4.5 bn to DKK 4.4-4.8 bn. This tells me first and foremost that the hearing aid market looks healthier than feared, and that innovation and new premium products can continue to create significant market share gains. This becomes very interesting for GN, because GN Hearing already delivered 9% organic growth in Q1. My expectation before GN's next report is therefore that Hearing can again deliver a strong quarter. A level around 7-9 % organic growth in Q2 will, in my assessment, be realistic, but that is my own estimate AND not GN's guidance. It is also positive for the value of the agreed DKK 17 bn transaction with Amplifon. GN is selling Hearing at a time when the industry is showing growth, product innovation, and opportunities for market share gains. But the biggest wildcard for the GN share will be Enterprise. If GN can combine: - 7-9 % Hearing growth - stabilization in Enterprise after -5 % in Q1 - better Gaming growth - maintained guidance - Amplifon transaction still on track ...then I think we have a fundamentally much stronger setup than the share price around DKK 100 immediately signals. And then the short positioning comes on top. Short interest, according to the latest data we have seen, has fallen from about 11.43% to 9.67%. That is still very high, but the direction is interesting. I am not building the GN case on a short squeeze. It must be the report, improved operations, and the value realization from Hearing that drives the share. But if GN delivers, while short positions continue to fall, it can naturally amplify the share price reaction. Demant's report is not proof that GN will deliver a strong Q2. Demant itself is gaining market share, and that must be respected. But as an industry read-through, I clearly think yesterday's report is positive for GN. Now GN itself must deliver. If Enterprise starts to turn around simultaneously with continued strong Hearing, DKK 100 could, in my assessment, become a much more interesting level than the market currently suggests. 🚀 Good luck to all GN shareholders.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt